Anti-rheumatic drug-prescribing behaviour of Australasian rheumatologists 1984-1994

P. G. Conaghan, M. Crotty, E. Oh, R. O. Day, P. M. Brooks

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


The prescribing behaviour of Australian and New Zealand rheumatologists was studied in 1994 using a questionnaire, and the results compared with a similar questionnaire administered in 1984. Perceived differences in efficacy and toxicity for disease-modifying anti-rheumatic drugs (DMARDs) and cytotoxics were reported. Over the decade, methotrexate and sulphasalazine have become the most commonly used anti-rheumatic agents, and methotrexate is clearly seen as the most effective drug. Wide variations in monitoring practices for DMARDs were reported, highlighting the need for cost-effectiveness studies on monitoring. There was low usage of functional outcome measurements in assessing patients.

Original languageEnglish
Pages (from-to)487-490
Number of pages4
JournalBritish Journal of Rheumatology
Issue number4
Publication statusPublished - 1 Apr 1997
Externally publishedYes


  • Cytotoxics
  • DMARDs
  • Outcome measurements
  • Rheumatoid arthritis


Dive into the research topics of 'Anti-rheumatic drug-prescribing behaviour of Australasian rheumatologists 1984-1994'. Together they form a unique fingerprint.

Cite this